S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Panacea Acquisition Corp. II (PANA) Stock Forecast, Price & News

0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
324 shs
Average Volume
1,562 shs
Market Capitalization
$173.19 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive PANA News and Ratings via Email

Sign-up to receive the latest news and ratings for Panacea Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter.

About Panacea Acquisition Corp. II

Panacea Acquisition Corp. II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.


See More Headlines

Industry, Sector and Symbol

Holding & other investment offices
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
Book Value
($0.31) per share


Net Income
$-740 thousand
Pretax Margin




Free Float
Market Cap
$173.19 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

0.33 out of 5 stars

Unclassified Sector

227th out of 724 stocks

Holding & Other Investment Offices Industry

219th out of 664 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Panacea Acquisition Corp. II (NASDAQ:PANA) Frequently Asked Questions

Who are Panacea Acquisition Corp. II's key executives?
Panacea Acquisition Corp. II's management team includes the following people:
  • Mr. Oleg Nodelman, Chairman & CEO (Age 45)
  • Mr. Scott Eric Perlen, Chief Financial Officer (Age 47)
  • Mr. Scott Platshon, Chief Operating Officer (Age 31)
  • Ms. Caroline Stout, Chief Investment Officer (Age 31)
  • Ms. Sarah Marriott, Sec. & Director (Age 45)
When did Panacea Acquisition Corp. II IPO?

(PANA) raised $150 million in an initial public offering on Wednesday, April 7th 2021. The company issued 15,000,000 shares at a price of $10.00 per share. Cowen acted as the underwriter for the IPO.

What is Panacea Acquisition Corp. II's stock symbol?

Panacea Acquisition Corp. II trades on the NASDAQ under the ticker symbol "PANA."

Who are Panacea Acquisition Corp. II's major shareholders?

Panacea Acquisition Corp. II's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Highbridge Capital Management LLC (9.21%), Sculptor Capital LP (4.68%), Glazer Capital LLC (2.37%), Victory Capital Management Inc. (1.43%), Radcliffe Capital Management L.P. (1.08%) and Karpus Management Inc. (0.38%).
View institutional ownership trends for Panacea Acquisition Corp. II

Which major investors are selling Panacea Acquisition Corp. II stock?

PANA stock was sold by a variety of institutional investors in the last quarter, including Glazer Capital LLC, and Victory Capital Management Inc..
View insider buying and selling activity for Panacea Acquisition Corp. II
or view top insider-selling stocks.

Which major investors are buying Panacea Acquisition Corp. II stock?

PANA stock was purchased by a variety of institutional investors in the last quarter, including Highbridge Capital Management LLC, Karpus Management Inc., Radcliffe Capital Management L.P., Sculptor Capital LP, Royal Bank of Canada, and Cohanzick Management LLC.
View insider buying and selling activity for Panacea Acquisition Corp. II
or or view top insider-buying stocks.

How do I buy shares of Panacea Acquisition Corp. II?

Shares of PANA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Panacea Acquisition Corp. II's stock price today?

One share of PANA stock can currently be purchased for approximately $9.73.

How much money does Panacea Acquisition Corp. II make?

Panacea Acquisition Corp. II has a market capitalization of $173.19 million.

How many employees does Panacea Acquisition Corp. II have?

Panacea Acquisition Corp. II employs 3 workers across the globe.

What is Panacea Acquisition Corp. II's official website?

The official website for Panacea Acquisition Corp. II is panacea.ecor1cap.com.

How can I contact Panacea Acquisition Corp. II?

Panacea Acquisition Corp. II's mailing address is 357 TEHAMA STREET FLOOR 3, SAN FRANCISCO CA, 94103. The company can be reached via phone at 415-966-0807 or via email at [email protected].

This page was last updated on 5/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.